statistiche ricercatore

DONADINI, MARCO PAOLO

Distribuzione geografica

Continente	#
NA - Nord America	7.275
EU - Europa	2.899
AS - Asia	2.144
SA - Sud America	265
Continente sconosciuto - Info sul continente non disponibili	136
AF - Africa	39
OC - Oceania	8
Totale	12.766

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	7.152
IT - Italia	1.501
SG - Singapore	692
CN - Cina	490
UA - Ucraina	372
HK - Hong Kong	281
VN - Vietnam	255
SE - Svezia	236
TR - Turchia	217
BR - Brasile	214
DE - Germania	178
IE - Irlanda	129
GB - Regno Unito	120
FR - Francia	103
FI - Finlandia	81
RU - Federazione Russa	77
IN - India	63
BD - Bangladesh	53
CA - Canada	52
MX - Messico	41
NL - Olanda	28
IQ - Iraq	17
ES - Italia	16
AR - Argentina	15
AT - Austria	15
PL - Polonia	14
JP - Giappone	13
NG - Nigeria	10
ZA - Sudafrica	10
CR - Costa Rica	9
EC - Ecuador	9
AU - Australia	7
BE - Belgio	7
CO - Colombia	7
JM - Giamaica	7
VE - Venezuela	7
AE - Emirati Arabi Uniti	6
MY - Malesia	6
TW - Taiwan	6
UZ - Uzbekistan	6
CL - Cile	5
IL - Israele	5
TH - Thailandia	5
AL - Albania	4
ID - Indonesia	4
NP - Nepal	4
PK - Pakistan	4
BO - Bolivia	3
CH - Svizzera	3
EG - Egitto	3
GT - Guatemala	3
KE - Kenya	3
LT - Lituania	3
PH - Filippine	3
SA - Arabia Saudita	3
TN - Tunisia	3
BA - Bosnia-Erzegovina	2
BG - Bulgaria	2
CI - Costa d'Avorio	2
EE - Estonia	2
ET - Etiopia	2
EU - Europa	2
HN - Honduras	2
JO - Giordania	2
KG - Kirghizistan	2
LB - Libano	2
MA - Marocco	2
NI - Nicaragua	2
PT - Portogallo	2
TT - Trinidad e Tobago	2
UY - Uruguay	2
AM - Armenia	1
AW - Aruba	1
BQ - ???statistics.table.value.countryCode.BQ???	1
CZ - Repubblica Ceca	1
DK - Danimarca	1
DO - Repubblica Dominicana	1
DZ - Algeria	1
GD - Grenada	1
GR - Grecia	1
GY - Guiana	1
HR - Croazia	1
IR - Iran	1
KH - Cambogia	1
KZ - Kazakistan	1
LK - Sri Lanka	1
MQ - Martinica	1
MU - Mauritius	1
NZ - Nuova Zelanda	1
PE - Perù	1
PY - Paraguay	1
SC - Seychelles	1
SV - El Salvador	1
TZ - Tanzania	1
Totale	12.633

Salva come PNG Salva come JPEG

Città	#
Milan	908
Fairfield	799
Ashburn	637
San Jose	547
Woodbridge	497
Singapore	400
Houston	356
Seattle	323
Wilmington	283
Chandler	280
Hong Kong	277
Jacksonville	272
Ann Arbor	270
Council Bluffs	254
Cambridge	240
Dallas	131
The Dalles	130
Chicago	127
Izmir	126
Dublin	124
Princeton	124
Los Angeles	101
Rome	93
Dearborn	92
Beijing	88
Nyköping	87
Boardman	85
Dong Ket	70
Lauterbourg	69
Santa Clara	69
New York	57
San Diego	48
Ho Chi Minh City	39
London	37
Hanoi	33
Ogden	33
Mexico City	31
Salt Lake City	26
Guangzhou	24
Helsinki	24
North Bergen	23
Naples	22
Denver	19
Tampa	19
Elk Grove Village	18
San Francisco	18
San Mateo	18
São Paulo	18
Afragola	17
Como	17
Orem	17
Phoenix	16
Buffalo	15
Shanghai	15
Chennai	14
Frankfurt am Main	14
Varese	14
Brooklyn	13
Hangzhou	13
Nuremberg	12
Toronto	12
Montreal	11
Schiffdorf	11
Atlanta	10
Brasília	10
Manchester	10
Tokyo	10
Warsaw	10
Washington	10
Abuja	9
Catania	9
Columbus	9
Düsseldorf	9
Falkenstein	9
Hefei	9
Miami	9
Stockholm	9
Bologna	8
Cavaria con Premezzo	8
Detroit	8
Kunming	8
Lancaster	8
Nanjing	8
Ralingen	8
Redmond	8
San José	8
Verona	8
Amsterdam	7
Bangalore	7
Brussels	7
Dulles	7
Haiphong	7
Johannesburg	7
Monza	7
Munich	7
Nanchang	7
Norwalk	7
Olgiate Olona	7
Shenzhen	7
Springfield	7
Totale	8.880

Salva come PNG Salva come JPEG

Nome	#
Establishing diagnostic criteria and treatment of subsegmental pulmonary embolism: a Delphi analysis of experts	413
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	328
Optimal treatment duration of venous thrombosis	282
Risk of recurrence of unusual site venous thromboembolism	267
Breadth of complications of long-term oral anticoagulant care	255
Novel oral anticoagulants for the prevention of venous thromboembolism in surgical patients	252
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	239
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	237
Patient selection for thromboprophylaxis in medical inpatients	229
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	228
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	223
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	220
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	215
Treating patients with cancer and acute venous thromboembolism	207
Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation	206
Clopidogrel plus aspirin versus aspirin alone for preventing cardiovascular events	205
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	204
Pulmonary Embolism in Medical-Surgical Critically Ill Patients	201
Oral rivaroxaban after symptomatic venous thromboembolism: the continued treatment study (EINSTEIN-Extension study).	199
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	197
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	195
Antidotes for the direct oral anticoagulants: What news?	194
Certoparin for the treatment and prevention of thrombosis: pharmacological profile and results from clinical studies	192
Age-adjusted D-dimer to rule out deep vein thrombosis: findings from the PALLADIO algorithm	192
Retrievable vena cava filters: a clinical review.	191
Aspirin plus clopidogrel vs aspirin alone for preventing cardiovascular events among patients at high risk for cardiovascular events	185
Evaluation of right ventricular function in patients with a previous episode of pulmonary embolism using tissue Doppler imaging.	184
Splanchnic vein thrombosis: new risk factors and management	184
Clinical approach to splanchnic vein thrombosis: Risk factors and treatment.	183
Brand name versus generic warfarin: a systematic review of the literature.	182
Efficacy and safety of dabigatran etexilate: a narrative review	176
JAK inhibitors and psoriatic arthritis: A systematic review and meta-analysis	176
Should alcohol be considered a minor protective factor for unprovoked venous thromboembolism?	175
Expert-Based Narrative Review on Compression UltraSonography (CUS) for Diagnosis and Follow-Up of Deep Venous Thrombosis (DVT)	174
Antiphospholipid Syndrome: A Challenging Hypercoagulable State with Systemic Manifestations	169
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors	168
Antithrombotic treatment of retinal vein occlusion: a position statement from the Italian Society on Thrombosis and Haemostasis (SISET)	166
Prognostic clinical prediction rules to identify a low-risk pulmonary embolism: a systematic review and meta-analysis.	160
Trattamento del tromboembolismo venoso con anticoagulanti tradizionali e di nuova generazione.	160
Incidence of symptomatic and asymptomatic chronic pulmonary hypertension in patients with a previous episode of pulmonary embolism: a prospective cohort study	154
Which patients with unprovoked VTE should receive extended anticoagulation? the minority.	153
Bleeding risk in randomized controlled trials comparing warfarin and aspirin: a systematic review and meta-analysis	150
Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?	144
Upper extremity deep vein thrombosis treated with direct oral anticoagulants: a multi-center real world experience	143
The short- and long-term risk of venous thromboembolism in patients with acute spinal cord injury: a prospective cohort study.	138
Prediction scores do not correlate with clinically adjudicated categories of pulmonary embolism in critically ill patients	138
PROPOSAL FOR THE INCLUSION OF LOW MOLECULAR WEIGHT HEPARINS FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS IN THE WHO MODEL LIST OF ESSENTIAL MEDICINES	135
Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): a position statement from the Italian Society for the Study of Haemostasis and Thrombosis (SISET)	126
Venous thromboembolism: pathophysiology, diagnosis and prophylaxis	123
Drug–Drug Interactions between Direct Oral Anticoagulants and Hepatitis C Direct-Acting Antiviral Agents: Looking for Evidence Through a Systematic Review	121
Recurrent bleeding and thrombotic events after resumption of oral anticoagulants following gastrointestinal bleeding: Communication from the ISTH SSC Subcommittee on Control of Anticoagulation	118
Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study.	112
null	109
Efficacy and safety of low-dose acetylsalicylic acid for the prevention of thromboembolic events in individuals positive for antiphospholipid antibodies: A systematic review and meta-analysis	107
Incidence and impact of anticoagulation-associated abnormal menstrual bleeding in women after venous thromboembolism	106
Anticoagulant treatment for Upper Extremity Deep Vein thrombosis: a systematic review and meta-analysis	102
Venous Thromboembolism Risk Associated with MIDLINE Catheters and Peripherally Inserted Central Catheters, a Systematic Review and Meta-Analysis	101
Risk of Deep Vein Thrombosis Following a Single Negative Whole-Leg Compression Ultrasound A Systematic Review and Meta-analysis	101
Management of bleeding in patients receiving conventional or new anticoagulants: a practical and case-based approach	100
Splanchnic vein thrombosis	100
Changes in the landscape of anticoagulation: a focus on direct oral anticoagulants	99
Manuale di emergenze medico-chirurgiche	99
Unusual site thrombosis.	97
Current and emerging drug strategies for the prevention of venous thromboembolism in acutely ill medical inpatients	90
Factor XI inhibitors for the prevention of cardiovascular disease: A new therapeutic approach on the horizon?	88
Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives	85
Long-term recurrence of venous thromboembolism after short-term treatment of symptomatic isolated distal deep vein thrombosis: A cohort study	85
Risk of intracranial bleeding in patients with primary brain cancer receiving therapeutic anticoagulation for venous thromboembolism: A meta-analysis	85
Antithrombotic treatment for retinal vein occlusion: a systematic review and meta-analysis	84
La trombosi venosa profonda e l’embolia polmonare	82
Venous and arterial thromboembolic risk of Janus kinase inhibitors: a systematic review with meta-analysis	77
Development of personalized thrombogenesis and thrombin generation assays to assess endothelial dysfunction in cardiovascular diseases	76
The Link Between Venous and Arterial Thrombosis: Is There a Role for Endothelial Dysfunction?	76
Perioperative Management of Patients who are Receiving Oral Anticoagulant Therapy	75
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	71
Steps towards simplifying the treatment of pulmonary embolism	67
Rates of venous thromboembolism and use of thromboprophylaxis after major orthopedic surgery in patients with congenital hemophilia A or B: a systematic review	64
Milvexian and other drugs targeting Factor XI: a new era of anticoagulation?	62
DOACs use in extreme body-weighted patients: results from the prospective START-register	57
Drug–drug interactions between DAAs and anticoagulants or antiplatelets: a position paper of the italian anticoagulation clinics	57
Implementing anticoagulation stewardship: the use of a dedicated mobile phone ‘app’ in the experience of the Italian Federation of Anticoagulation linics (FCSA)	56
Geographical and ethnoracial differences in venous thromboembolism and anticoagulation: An expanding horizon	56
Use of artificial intelligence and radiomics for risk stratification in patients with pulmonary embolism: New tools for an old problem	56
The Clinical Impact of the Pulmonary Embolism Severity Index on the Length of Hospital Stay of Patients with Pulmonary Embolism: A Randomized Controlled Trial	53
More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study	43
Distal deep vein thrombosis: is there a way out of this dark forest?	33
Thrombotic events after vaccination for covid-19 in Italy: a report from the Italian society on thrombosis and haemostasis registry	31
Prescribing patterns and clinician preferences for direct oral anticoagulant use in unusual site venous thromboembolism: a cross-sectional analysis from the Direct oral anticoagulants in Unusual Site venous Thromboembolism (DUST) study	27
Results from an Expert-Based Cross-Sectional National Survey on Antithrombotic TREATment After PEDiatric Peripheral Vascular Injuries. (The TREAT-PED-PVI Survey)	25
Exploring Italian nursing staff in anticoagulation clinics: a cluster-based description of current practice, nurse self-efficacy, job satisfaction, and interprofessional collaboration	16
Totale	12.766

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	51.944
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	51.944

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	523	0	0	0	36	58	36	33	50	43	123	64	80
2022/2023	760	78	64	28	96	57	158	10	84	123	26	19	17
2023/2024	1.432	244	234	227	274	278	60	2	26	60	8	18	1
2024/2025	1.380	8	12	187	18	19	89	58	90	90	107	297	405
2025/2026	3.061	231	141	142	304	214	230	562	220	410	246	167	194
2026/2027	1.128	128	173	432	395	0	0	0	0	0	0	0	0
Totale													12.766